Graves’ Ophthalmopathy: Symptoms, Causes, and Treatment Options

Introduction

Graves’ ophthalmopathy, also known as thyroid eye disease (TED), is an autoimmune condition that affects the eyes and is often associated with Graves’ disease, a thyroid disorder. First identified in the 19th century, Graves’ ophthalmopathy causes inflammation and swelling in the muscles and tissues around the eyes, leading to various symptoms that can impact both vision and appearance. While it is most commonly linked to hyperthyroidism (an overactive thyroid), it can also occur in individuals with normal or underactive thyroid function.

This article provides a comprehensive overview of Graves’ ophthalmopathy, covering its risk factors, symptoms, diagnostic tests, treatment options (including medications and procedures), and practical steps patients can take to manage symptoms at home. By understanding the condition, patients can actively participate in their care and work closely with healthcare providers to determine the most effective treatment plan.

What is Graves’ Ophthalmopathy?

Graves’ ophthalmopathy is an autoimmune disorder in which the immune system mistakenly attacks the tissues around the eyes, leading to inflammation, swelling, and sometimes damage to the muscles and connective tissues that control eye movement. As the condition progresses, symptoms such as bulging eyes (proptosis), double vision, and eye irritation may develop.

The progression of Graves’ ophthalmopathy varies from person to person. In some cases, it remains mild, while in others, it can lead to severe complications, including vision loss. The disease typically follows two phases: an active phase, where inflammation and symptoms worsen, and an inactive phase, where inflammation subsides but some residual effects may persist.

Graves’ ophthalmopathy is relatively uncommon, affecting about 25-50% of people with Graves’ disease. It is more prevalent in women than men and usually occurs in adults aged 30 to 50, though it can also affect children and older adults. Early diagnosis and treatment are crucial to managing the condition and preventing long-term complications.

Risk Factors for Developing Graves’ Ophthalmopathy

Lifestyle Risk Factors

Certain lifestyle factors can increase the risk of developing Graves’ ophthalmopathy, with smoking being one of the most significant. Research shows that smokers are up to eight times more likely to develop the condition than non-smokers. Smoking also worsens the severity of the disease and reduces the effectiveness of treatments. Quitting smoking is one of the most important steps patients can take to lower their risk and improve their overall health.

Other lifestyle factors, such as stress, may also contribute to triggering or worsening Graves’ ophthalmopathy. While stress alone is not a direct cause, it can exacerbate autoimmune conditions by affecting the immune system. Managing stress through relaxation techniques, regular exercise, and a healthy diet may help reduce the risk of flare-ups.

Medical Risk Factors

The primary medical risk factor for Graves’ ophthalmopathy is having Graves’ disease, an autoimmune disorder that causes the thyroid to produce too much thyroid hormone. People with hyperthyroidism are at higher risk of developing eye symptoms, especially if their thyroid condition is not well-controlled. However, not everyone with Graves’ disease will develop ophthalmopathy.

Other medical conditions, such as hypothyroidism (underactive thyroid) or Hashimoto’s thyroiditis, may also be linked to Graves’ ophthalmopathy, though the connection is less common. Additionally, patients who have undergone radioactive iodine therapy for hyperthyroidism may have a slightly increased risk of developing or worsening eye symptoms.

Genetic and Age-Related Risk Factors

Genetics also play a role in the development of Graves’ ophthalmopathy. Individuals with a family history of autoimmune diseases, particularly thyroid disorders, are more likely to develop the condition. Specific genetic markers, such as certain variations in the HLA (human leukocyte antigen) gene, have been associated with an increased risk of autoimmune diseases, including Graves’ ophthalmopathy.

Age is another factor. While Graves’ ophthalmopathy can occur at any age, it is most commonly diagnosed in adults between 30 and 50. Women are more likely to develop the condition than men, although men who do develop it tend to experience more severe symptoms.

Clinical Manifestations of Graves’ Ophthalmopathy

Protruding Eyes (Exophthalmos)

Protruding eyes, or exophthalmos, occur in about 60% of patients with Graves’ ophthalmopathy. This symptom is more common in the early stages and tends to be more pronounced in smokers and those with severe thyroid dysfunction. Exophthalmos results from inflammation and swelling of the tissues and muscles behind the eyes, pushing the eyeballs forward. This can cause discomfort, difficulty closing the eyes, and an increased risk of eye infections or dryness.

Double Vision (Diplopia)

Double vision, or diplopia, affects around 30% of patients with Graves’ ophthalmopathy. It occurs when the muscles controlling eye movement become stiff or swollen, leading to misalignment. This misalignment causes the brain to receive two different images from each eye, resulting in double vision. Diplopia can be intermittent at first, often worsening as the disease progresses. It is more common in moderate to severe cases and can significantly impact daily activities like reading or driving.

Eyelid Retraction

Eyelid retraction is seen in about 90% of patients with Graves’ ophthalmopathy, making it one of the most common symptoms. It occurs when the upper eyelid is pulled back, exposing more of the eye than usual. This is caused by inflammation and fibrosis (scarring) of the muscles controlling the eyelids. Eyelid retraction can give the eyes a wide, staring appearance and may contribute to dryness and irritation, as the eyes are less protected from environmental factors like wind and dust.

Dry Eyes

Dry eyes affect about 50% of patients with Graves’ ophthalmopathy. Inflammation in the tissues around the eyes can interfere with tear production or distribution. Additionally, if the eyelids cannot close fully due to exophthalmos or eyelid retraction, the eyes may not be properly lubricated. Dry eyes can cause discomfort, a gritty sensation, and an increased risk of corneal damage if untreated.

Redness or Swelling Around the Eyes

Redness and swelling around the eyes, also known as periorbital edema, are present in about 40% of patients. This occurs when the tissues around the eyes become inflamed, causing fluid to accumulate. The swelling can lead to discomfort, a feeling of pressure, and may worsen throughout the day. Redness is often a sign of inflammation and can be accompanied by irritation or a burning sensation.

Vision Changes

Vision changes, including blurriness or decreased visual acuity, occur in about 10-20% of patients with Graves’ ophthalmopathy. These changes can result from pressure on the optic nerve due to swelling behind the eye or from corneal damage caused by dry eyes. In severe cases, untreated vision changes can lead to permanent vision loss, making early diagnosis and treatment essential.

Eye Pain

Eye pain is reported by about 30% of patients with Graves’ ophthalmopathy. This pain can range from mild discomfort to severe aching and is often caused by inflammation and swelling of the tissues around the eyes. The pain may worsen with eye movement or exposure to bright light. In some cases, it is due to dryness or corneal irritation.

Sensitivity to Light (Photophobia)

Sensitivity to light, or photophobia, affects about 20% of patients. This symptom occurs when inflamed tissues around the eyes make them more sensitive to bright lights. Photophobia can cause discomfort or pain when exposed to sunlight, fluorescent lights, or even computer screens. It is often associated with other symptoms like dry eyes or redness and can make it difficult to perform daily tasks in well-lit environments.

Tearing (Epiphora)

Excessive tearing, or epiphora, occurs in about 30% of patients with Graves’ ophthalmopathy. This symptom can result from irritation due to dryness, inflammation, or exposure to environmental factors. Paradoxically, even though dry eyes are common, the body may produce excess tears in response to irritation. However, these tears are often of poor quality and do not adequately lubricate the eyes, leading to a cycle of dryness and tearing.

Difficulty Closing Eyes

Difficulty closing the eyes, or lagophthalmos, affects around 40% of patients. This occurs when swelling and protrusion prevent the eyelids from fully closing. Incomplete closure can lead to dryness, irritation, and an increased risk of corneal damage. Patients may notice that their eyes feel dry or gritty upon waking, as the eyes are not properly protected during sleep.

Diagnostic Evaluation of Graves’ Ophthalmopathy

The diagnosis of Graves’ ophthalmopathy is made through a combination of patient history, physical examination, and diagnostic tests. A healthcare provider will assess symptoms such as eye protrusion, double vision, or eyelid retraction and inquire about any history of thyroid disease. A physical examination will focus on the eyes and surrounding tissues. To confirm the diagnosis and assess the severity of the condition, several diagnostic tests may be ordered. These tests help evaluate thyroid function, the extent of eye involvement, and the presence of inflammation or other abnormalities.

Thyroid Function Tests

Test Information: Thyroid function tests are blood tests that measure thyroid hormone levels, including thyroxine (T4), triiodothyronine (T3), and thyroid-stimulating hormone (TSH). These tests are crucial because Graves’ ophthalmopathy is closely linked to thyroid dysfunction, particularly hyperthyroidism. The test involves drawing a small blood sample, usually from the arm, which is then analyzed in a lab to determine hormone levels. Abnormal thyroid hormone levels can indicate an overactive thyroid, often associated with Graves’ disease.

Results that Indicate Graves’ Ophthalmopathy: In patients with Graves’ ophthalmopathy, thyroid function tests often show elevated T4 and T3 levels, along with low TSH levels, indicating hyperthyroidism. However, some patients may have normal thyroid hormone levels, a condition known as euthyroid Graves’ ophthalmopathy. If test results are normal but symptoms persist, additional tests may be needed to confirm the diagnosis. If the test is negative, the healthcare provider may explore other causes of the symptoms, such as other autoimmune or inflammatory conditions.

CT Scan

Test Information: A computed tomography (CT) scan uses X-rays to create detailed cross-sectional images of the body. For Graves’ ophthalmopathy, a CT scan of the orbits (eye sockets) helps visualize the muscles and tissues around the eyes. The patient lies on a table that slides into a large, doughnut-shaped machine, which takes multiple X-ray images from different angles. These images are combined to create a detailed picture of the eye structures, particularly useful for assessing muscle enlargement and tissue swelling behind the eyes.

Results that Indicate Graves’ Ophthalmopathy: In patients with Graves’ ophthalmopathy, a CT scan may show thickening of the extraocular muscles (those controlling eye movement) and swelling of the tissues behind the eyes. These findings indicate inflammation and fibrosis, characteristic of the disease. If no abnormalities are found, the provider may consider other conditions, such as orbital tumors or infections. In some cases, further imaging tests, like an MRI, may be recommended for additional information.

MRI

Test Information: Magnetic resonance imaging (MRI) is a non-invasive test that uses powerful magnets and radio waves to create detailed images of the body’s internal structures. An MRI of the orbits provides a clear view of the muscles, tissues, and nerves around the eyes. The patient lies on a table that slides into a large, tube-like machine. Unlike a CT scan, MRI does not use radiation, making it a safer option for some patients. MRI is particularly useful for assessing soft tissue changes and detecting optic nerve compression, which can lead to vision loss.

Results that Indicate Graves’ Ophthalmopathy: In patients with Graves’ ophthalmopathy, an MRI may reveal thickening of the extraocular muscles and inflammation of the tissues behind the eyes. In severe cases, the MRI may show optic nerve compression, which can lead to vision changes or loss. If the MRI results are normal, the provider may consider other causes of the symptoms, such as other autoimmune or inflammatory conditions. If symptoms persist despite negative results, further evaluation may be necessary.

Ultrasound

Test Information: Ultrasound is a non-invasive test that uses sound waves to create images of the body’s internal structures. For Graves’ ophthalmopathy, an ultrasound of the orbits helps visualize the muscles and tissues around the eyes. The test involves placing a small handheld device called a transducer on the skin around the eyes. The transducer emits sound waves that bounce off the tissues and are converted into images on a screen. Ultrasound is a quick and painless test that provides valuable information about muscle enlargement and tissue swelling.

Results that Indicate Graves’ Ophthalmopathy: In patients with Graves’ ophthalmopathy, an ultrasound may show thickening of the extraocular muscles and swelling of the tissues behind the eyes. These findings are consistent with the inflammation and fibrosis seen in the disease. If the ultrasound results are normal, the provider may consider other conditions, such as orbital tumors or infections. Further imaging tests, like a CT scan or MRI, may be recommended for additional information.

What if All Tests are Negative but Symptoms Persist?

If all diagnostic tests return negative but symptoms of Graves’ ophthalmopathy persist, it is essential to follow up with your healthcare provider. They may recommend additional testing or refer you to a specialist, such as an ophthalmologist or endocrinologist, for further evaluation. In some cases, symptoms may be caused by other conditions that mimic Graves’ ophthalmopathy, such as orbital tumors or other autoimmune diseases. Your provider will work with you to determine the underlying cause of your symptoms and develop an appropriate treatment plan.

html

Treatment Options for Graves’ Ophthalmopathy

Medications for Graves’ Ophthalmopathy

Methimazole

Definition: Methimazole is an antithyroid medication that reduces the production of thyroid hormones. It is commonly prescribed to treat hyperthyroidism, including Graves’ disease.

How and When It’s Used: Methimazole works by inhibiting the thyroid gland’s ability to produce excess hormones. It is often the first-line treatment for hyperthyroidism, particularly in patients with Graves’ disease. Taken orally, the dosage is adjusted based on thyroid hormone levels. Methimazole is typically used in the early stages of Graves’ ophthalmopathy to help regulate thyroid function, which may indirectly improve eye symptoms.

Expected Outcomes: Patients can expect a reduction in thyroid hormone levels within weeks to months, which may help alleviate some symptoms of Graves’ ophthalmopathy, such as eye irritation and swelling. However, it may not directly address all eye-related issues.

Propylthiouracil (PTU)

Definition: Propylthiouracil (PTU) is another antithyroid medication that reduces thyroid hormone production. It is often used when Methimazole is not suitable.

How and When It’s Used: PTU is typically prescribed for patients who cannot tolerate Methimazole or in specific situations, such as during pregnancy. Like Methimazole, PTU blocks the thyroid gland’s ability to produce excess hormones. It is taken orally and monitored through regular blood tests. While PTU is not a direct treatment for Graves’ ophthalmopathy, it helps manage the underlying thyroid condition.

Expected Outcomes: Similar to Methimazole, PTU helps lower thyroid hormone levels, which may indirectly improve some symptoms of Graves’ ophthalmopathy. However, it may take several weeks to notice significant improvements.

Corticosteroids

Definition: Corticosteroids, such as prednisone, are powerful anti-inflammatory medications that reduce swelling and inflammation in the eyes.

How and When It’s Used: Corticosteroids are often used in moderate to severe cases of Graves’ ophthalmopathy to reduce inflammation and swelling around the eyes. They can be administered orally or intravenously, depending on the severity of the condition. Corticosteroids are typically prescribed when eye symptoms cause significant discomfort or vision problems.

Expected Outcomes: Patients may experience reduced eye swelling and discomfort within days to weeks of starting corticosteroids. However, long-term use is generally avoided due to potential side effects.

Rituximab

Definition: Rituximab is a monoclonal antibody that targets specific immune cells involved in the autoimmune response of Graves’ disease.

How and When It’s Used: Rituximab is typically reserved for severe cases of Graves’ ophthalmopathy that do not respond to corticosteroids or other treatments. It is administered intravenously and works by reducing the activity of immune cells that contribute to inflammation and tissue damage around the eyes.

Expected Outcomes: Patients may see a reduction in eye inflammation and improvement in symptoms over several weeks to months. However, Rituximab is not always effective for all patients.

Teprotumumab

Definition: Teprotumumab is a targeted therapy specifically approved for treating thyroid eye disease (Graves’ ophthalmopathy). It works by inhibiting the insulin-like growth factor-1 receptor (IGF-1R), which plays a role in the disease process.

How and When It’s Used: Teprotumumab is typically used in patients with moderate to severe Graves’ ophthalmopathy, especially when other treatments have not been effective. It is administered through a series of intravenous infusions over several months. Teprotumumab is one of the few treatments that directly targets the underlying mechanisms of Graves’ ophthalmopathy.

Expected Outcomes: Many patients experience significant improvement in eye symptoms, including reduced bulging, swelling, and double vision, within a few months of starting treatment.

Selenium

Definition: Selenium is a trace mineral with antioxidant properties that may help reduce inflammation in patients with mild Graves’ ophthalmopathy.

How and When It’s Used: Selenium supplements are often recommended for patients with mild Graves’ ophthalmopathy to help reduce oxidative stress and inflammation in the eye tissues. It is taken orally, usually as a daily supplement. Selenium is considered a supportive treatment rather than a primary therapy.

Expected Outcomes: Studies suggest selenium may help slow the progression of mild Graves’ ophthalmopathy and improve eye symptoms over several months.

Beta-blockers

Definition: Beta-blockers are medications that help manage symptoms of hyperthyroidism, such as rapid heart rate and anxiety, but they do not directly treat Graves’ ophthalmopathy.

How and When It’s Used: Beta-blockers are often prescribed to patients with hyperthyroidism to control symptoms like palpitations, tremors, and anxiety. While they do not directly affect the eyes, managing these symptoms can improve overall well-being and reduce stress, which may indirectly benefit patients with Graves’ ophthalmopathy.

Expected Outcomes: Patients can expect relief from hyperthyroid symptoms within hours to days of starting beta-blockers, though eye symptoms may not be directly affected.

Antithyroid Drugs

Definition: Antithyroid drugs, such as Methimazole and PTU, reduce thyroid hormone production.

How and When It’s Used: Antithyroid drugs manage hyperthyroidism in patients with Graves’ disease. By controlling thyroid hormone levels, these drugs can help prevent the worsening of Graves’ ophthalmopathy. They are typically used in the early stages of treatment and may be combined with other therapies for the eyes.

Expected Outcomes: Patients can expect a reduction in thyroid hormone levels within a few weeks to months, which may help stabilize or improve eye symptoms over time.

Procedures for Treating Graves’ Ophthalmopathy

Orbital Decompression Surgery

Definition: Orbital decompression surgery creates more space in the eye socket by removing bone or fat, relieving pressure on the eyes.

How and When It’s Used: This surgery is typically reserved for patients with severe Graves’ ophthalmopathy who experience vision-threatening complications, such as optic nerve compression. It is also used to reduce the bulging of the eyes (proptosis) in advanced cases. The procedure is performed by an ophthalmic surgeon and may require a hospital stay.

Expected Outcomes: Patients can expect significant relief from eye pressure and bulging, with improvements in vision and appearance. Recovery time varies, but most patients see benefits within weeks to months.

Radiation Therapy

Definition: Radiation therapy uses targeted radiation to reduce inflammation and swelling in the tissues around the eyes.

How and When It’s Used: Radiation therapy is typically used in moderate to severe cases of Graves’ ophthalmopathy, especially when corticosteroids are not effective. It is delivered in small doses over several sessions and is aimed at reducing inflammation in the eye muscles and tissues. Radiation therapy is often combined with other treatments, such as corticosteroids.

Expected Outcomes: Patients may experience gradual improvement in eye symptoms over several weeks to months. However, the full benefits of radiation therapy may take time to become apparent.

Improving Graves’ Ophthalmopathy and Seeking Medical Help

In addition to medical treatments, several home remedies can help alleviate symptoms of Graves’ ophthalmopathy and improve your quality of life:

1. Cold compresses: Applying cold compresses to your eyes can help reduce swelling and discomfort.
2. Eye protection: Wearing sunglasses or protective eyewear can shield your eyes from wind, dust, and bright light.
3. Avoiding smoke and irritants: Smoke and other environmental irritants can worsen eye symptoms, so it’s important to avoid them.
4. Maintaining a healthy diet: Eating a balanced diet rich in antioxidants can support overall eye health.
5. Staying hydrated: Drinking plenty of water can help keep your eyes moist and reduce irritation.
6. Using artificial tears: Over-the-counter artificial tears can help relieve dryness and irritation.
7. Elevating the head while sleeping: Keeping your head elevated can reduce swelling around the eyes.
8. Practicing stress management techniques: Stress can exacerbate symptoms, so relaxation techniques like meditation or yoga may be beneficial.
9. Regular eye check-ups: Regular visits to your eye doctor can help monitor the progression of the disease and adjust treatments as needed.

If you experience worsening symptoms, such as double vision, severe eye pain, or vision loss, it’s important to seek medical help promptly. Telemedicine offers a convenient way to consult with healthcare providers from the comfort of your home, allowing for timely adjustments to your treatment plan.

Living with Graves’ Ophthalmopathy: Tips for Better Quality of Life

Living with Graves’ ophthalmopathy can be challenging, but there are steps you can take to improve your quality of life. In addition to following your prescribed treatment plan, consider incorporating the following tips:

1. Stay informed about your condition and treatment options.
2. Communicate openly with your healthcare provider about any changes in your symptoms.
3. Protect your eyes from irritants and bright light by wearing sunglasses or protective eyewear.
4. Use lubricating eye drops to keep your eyes moist and reduce irritation.
5. Practice stress management techniques to help reduce the impact of stress on your condition.
6. Maintain a healthy lifestyle, including a balanced diet and regular exercise, to support overall well-being.

Conclusion

Graves’ ophthalmopathy is a complex condition that affects the eyes and can significantly impact your quality of life. Early diagnosis and treatment are crucial to managing symptoms and preventing complications. By working closely with your healthcare provider and following a comprehensive treatment plan, you can improve your symptoms and protect your vision.

If you’re experiencing symptoms of Graves’ ophthalmopathy or have been diagnosed with Graves’ disease, our telemedicine practice is here to help. Schedule a virtual consultation with one of our primary care providers to discuss your symptoms and explore treatment options tailored to your needs.

James Kingsley

Learn More